Navigation Links
Ritter Pharmaceuticals Hires Dr. Howard Foyt as Executive Vice President, Development & Chief Medical Officer
Date:9/10/2009

LOS ANGELES, Sept. 10 /PRNewswire/ -- Ritter Pharmaceuticals, Inc. (Ritter) has hired Howard Foyt, M.D., Ph.D., FACP as its new Executive VP, Development & Chief Medical Officer. Dr. Foyt brings 13 years of expertise in drug development to Ritter, as the Company prepares to file an IND for its therapy for Lactose Intolerance.

Dr. Foyt will join Ritter's senior management team and oversee the Company's clinical development efforts. Ritter will take advantage of Dr. Foyt's leadership in drug development within big pharma and biotech companies. For the past three years, Dr. Foyt served as VP, Clinical Development and Chief Medical Officer at Metabasis Therapeutics, where he was responsible for five drugs in clinical development over multiple therapeutic areas. Dr. Foyt had previously worked at Pfizer, where he served as Senior Director and Site Head - Diabetes & Obesity, and earlier at Parke-Davis for over ten years participating in the clinical development of multiple drugs mainly in the metabolic disease field. Prior to joining Parke-Davis, Dr. Foyt was on the faculty at the University of Texas Medical Branch, Galveston, TX. He earned his medical degree and Ph.D. in Cell Biology from Baylor College of Medicine. Dr. Foyt completed his residency in internal medicine at Baylor and an endocrinology fellowship at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

"We are thrilled to have Dr. Foyt on our team," said Ritter Pharmaceuticals' President and CEO Andrew Ritter. "His breadth of clinical development and drug development experience will bring a great deal of scientific rigor and creativity to our development plans."

About Ritter Pharmaceuticals

Ritter is committed to the discovery, development and commercialization of innovative therapies for gastrointestinal diseases. The Company's scientific platform
'/>"/>

SOURCE Ritter Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Reportlinker Adds US and European Radiopharmaceuticals Market Report
2. Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
3. Isis Pharmaceuticals to Present at Morgan Stanleys Global Healthcare Unplugged Conference
4. Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
5. Jazz Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Amira Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
8. Steven Holtzman Joins Satori Pharmaceuticals Board of Directors
9. Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
10. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2010
11. Isis Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... York, NY (PRWEB) , ... July 01, 2015 , ... ... which DNA is wound, histones, remain constant in the brain, never changing after development ... have discovered that histones are steadily replaced in brain cells throughout life – a ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... such as organically raised chickens and eggs. Eating organic foods and products can ... cleaner and more environmentally friendly than production chicken farming. Choosing home raised chickens ...
(Date:7/1/2015)... ... July 01, 2015 , ... OncLive® ... Hospital Corporation of America (HCA), as it further expands its Strategic Alliance Partnership ... , With this new partnership, OncLive’s editorial and marketing teams will collaborate with ...
(Date:7/1/2015)... , ... - (PRWEB) July 01, 2015 , ... Lisa ... nationwide virtual 5K on August 15-16th (MSG Keys’ birthday) in memory of her late ... highly decorated soldier and recipient of the Bronze Star Medal, died during a Special ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... Force, contributing to newly released white paper: “Pro-actively Identifying the High-Cost Patient Population: ... July 1st and is available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... The body parts industry, which suffered two recent scams, is ... United States . According to official reports, the billion-dollar industry ... call for a doubling of FDA inspections. ,From ... of inspections, and accordingly, the 153 searches, have uncovered no ...
... even after they stop smoking, says a new study, ... smoking ceases . ,The new finding is the ... with bronchial inflammation, it will continue even after they ... team of researchers in respiratory medicine including New Zealand ...
... international team of researchers has found evidence that people ... sleep disorder called restless legs syndrome (RLS) are ... ,RLS is a common and debilitating sleep disorder that ... people worldwide. It produces an intense, often irresistible urge ...
... even at the cost of lives, are turning out to ... are far less likely than whites to get specialized ... leave them more vulnerable to future fatal attacks. ... American Medical Association, tracked 1.2 million Medicare patients at least ...
... A US court has authorised Israeli generic medicines group Teva ... patent lawsuit by Novartis, the Swiss pharmaceutical group said on ... rejected on Monday a request from Novartis to stop Teva ... pending a trial in the case, the Swiss group said ...
... down on Madhya Pradesh Tuesday, taking temperatures to more than 46 ... heat wave claimed six more lives taking the toll to ... saying the hot weather would persist for the next two days. ... Morena and Damoh. ,The mercury soared to more ...
Cached Medicine News:Health News:Body Parts Industry Of U.S Under Investigation 2Health News:Boffins Find Link Between Common Sleep Disorder and Hypertension 2Health News:Racial Discrimination Takes The Nobility Out Of Doctoring 2
(Date:7/1/2015)... -- AVACEN, Inc. announced today the issue by the US Patent ... platform supporting its unique Dry Heat Therapy AVACEN 100 product. ... http://photos.prnewswire.com/prnh/20150630/227364LOGO ... Methods And Apparatus For Therapeutic Application of Thermal Energy shields ... use, referred to by the company as the AVACEN ...
(Date:7/1/2015)... has acquired West Bend Assisted Living Pharmacy ( ... a proven track record for excellent service to individuals ... involved in their care. Both companies have strong reputations ... to their customers. Genoa ... dedicated to the behavioral health community and those affiliated ...
(Date:7/1/2015)... BALTIMORE , July 1, 2015   Continental Clinical Solutions (Continental) announced it ... from private practice to accommodate increased volume in clinical studies and demand for unique patient ... ... ... ...
Breaking Medicine Technology:AVACEN Medical Patent Issued 2Genoa, a QoL Healthcare Company Acquires West Bend Assisted Living Pharmacy 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4
... NxStage Medical, Inc. (Nasdaq: NXTM ), a ... addition of Nancy J. Ham to the Company,s Board ... Mr. Silverstein, General Partner of OrbiMed, joined ... in which OrbiMed was the lead investor.  "Jonathan has ...
... Calif., Jan. 24, 2011 Biomerix Corporation announced today ... REVIVE™ soft tissue repair mesh allowing for the marketing ...    REVIVE received 510(k) clearance from the U.S. Food ... REVIVE is constructed of the Biomerix Biomaterial™, a proprietary, ...
Cached Medicine Technology:NxStage® Appoints Nancy J. Ham to Its Board of Directors and Announces Resignation of Board Member Jonathan T. Silverstein 2Biomerix Granted CE Mark for its REVIVE™ Soft Tissue Repair Mesh 2
Inquire...
Inquire...
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Medicine Products: